| Title |
Summary of Evidence on Immediate Statins Therapy Following Aneurysmal Subarachnoid Hemorrhage
|
|---|---|
| Published in |
Neurocritical Care, August 2011
|
| DOI | 10.1007/s12028-011-9596-6 |
| Pubmed ID | |
| Authors |
M. Y. Tseng, The Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage |
| Abstract |
Statins were shown to have neuroprotective effects, with reduced vasospasm and delayed ischemic deficits in statin-treated patients after aneurysmal subarachnoid hemorrhage in two small, randomized, controlled clinical trials published in 2005. This review consolidated data from available published studies evaluating statin treatment for subarachnoid hemorrhage. A literature search was conducted to identify original research studies published through October 2010 testing immediate treatment with a statin in statin-naïve patients following aneurysmal SAH. Six randomized controlled clinical trials and four observational studies were identified. Despite inconsistent results among studies, a meta-analysis of randomized controlled data showed a significant reduction in delayed ischemic deficits with statins. Effect on vasospasm was more difficult to determine, due to differences in definitions used among studies. Interpretations from observational studies were limited by the use of relatively small sample sizes, historical controls, and treatment variability. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 4 | 5% |
| United States | 1 | 1% |
| Spain | 1 | 1% |
| Unknown | 69 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 15 | 20% |
| Researcher | 13 | 17% |
| Professor > Associate Professor | 9 | 12% |
| Other | 8 | 11% |
| Student > Master | 7 | 9% |
| Other | 18 | 24% |
| Unknown | 5 | 7% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 58 | 77% |
| Neuroscience | 5 | 7% |
| Agricultural and Biological Sciences | 2 | 3% |
| Arts and Humanities | 1 | 1% |
| Environmental Science | 1 | 1% |
| Other | 2 | 3% |
| Unknown | 6 | 8% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2012.
All research outputs
#18,835,246
of 23,340,595 outputs
Outputs from Neurocritical Care
#1,299
of 1,521 outputs
Outputs of similar age
#101,131
of 121,976 outputs
Outputs of similar age from Neurocritical Care
#15
of 17 outputs
Altmetric has tracked 23,340,595 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,521 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,976 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.